Your browser doesn't support javascript.
loading
Population Pharmacokinetics and Exposure-Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.
Miao, Xin; Wu, Liviawati S; Lin, Shun Xin Wang; Xu, Yan; Chen, Yang; Iwaki, Yuki; Kobos, Rachel; Stephenson, Tara; Kemmerer, Kristy; Uhlar, Clarissa M; Banerjee, Arnob; Goldberg, Jenna D; Trancucci, Danielle; Apte, Amit; Verona, Raluca; Pei, Lixia; Desai, Rachit; Hickey, Kathleen; Su, Yaming; Ouellet, Daniele; Samtani, Mahesh N; Guo, Yue; Garfall, Alfred L; Krishnan, Amrita; Usmani, Saad Z; Zhou, Honghui; Girgis, Suzette.
Afiliação
  • Miao X; Janssen Research & Development, Spring House, PA, USA. xmiao0831@gmail.com.
  • Wu LS; Janssen Research & Development, South San Francisco, CA, USA.
  • Lin SXW; Janssen Research & Development, Spring House, PA, USA.
  • Xu Y; Janssen Research & Development, Spring House, PA, USA.
  • Chen Y; Janssen Research & Development, Spring House, PA, USA.
  • Iwaki Y; Janssen Pharmaceutical KK, Tokyo, Japan.
  • Kobos R; Janssen Research & Development, Raritan, NJ, USA.
  • Stephenson T; Janssen Research & Development, Spring House, PA, USA.
  • Kemmerer K; Janssen Research & Development, Spring House, PA, USA.
  • Uhlar CM; Janssen Research & Development, Spring House, PA, USA.
  • Banerjee A; Janssen Research & Development, Spring House, PA, USA.
  • Goldberg JD; Janssen Research & Development, Raritan, NJ, USA.
  • Trancucci D; Janssen Research & Development, Raritan, NJ, USA.
  • Apte A; Janssen Research & Development, Raritan, NJ, USA.
  • Verona R; Janssen Research & Development, Spring House, PA, USA.
  • Pei L; Janssen Research & Development, Raritan, NJ, USA.
  • Desai R; Janssen Research & Development, Raritan, NJ, USA.
  • Hickey K; Janssen Research & Development, Spring House, PA, USA.
  • Su Y; Janssen Research & Development, Raritan, NJ, USA.
  • Ouellet D; Janssen Research & Development, Spring House, PA, USA.
  • Samtani MN; Janssen Research & Development, Spring House, PA, USA.
  • Guo Y; Janssen Research & Development, Spring House, PA, USA.
  • Garfall AL; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Krishnan A; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Usmani SZ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhou H; Janssen Research & Development, Spring House, PA, USA.
  • Girgis S; Janssen Research & Development, Spring House, PA, USA.
Target Oncol ; 18(5): 667-684, 2023 09.
Article em En | MEDLINE | ID: mdl-37713090
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Neutropenia / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Neutropenia / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos